CDMO Session: CARBOGEN AMCIS, an interview with Stephan Fritschi

In the latest episode of the PharmaSource CDMO Sessions, we speak Stephan Fritchi, Executive Vice President Business Units for CARBOGEN AMCIS.
Stephan is responsible for operations across all CARBOGEN AMCIS manufacturing sites worldwide, including sites in France, four in Switzerland, United Kingdom, Netherlands and China.
The contract manufacturer supports customers at all stages of drug development, from clinical trials to being released on the market as a commercial product. Their services include Highly Potent API facilities and a clean room for Antibody Drug Conjugates. 

“We are specialists in providing services in developing chemical processes and produce drugs up to the final product. Depending on the nature of the projects, we can either run our activities from a single site or using multiple sites together." says Stephan.
“We normally start our relationship with clients at a very early phase through clinical phases and then we build up a trustworthy relationship. This normally lasts five to 10 years when finally, if the product is successful on the market, we will produce commercially.”